Lithium Hydroxide → n-[(1,3-Benzodioxol-5-yl)methyl]-1-[2-(1h-imidazol-1-yl)pyrimidin-4-yl]indole-6-carboxamide

HRID 352619

反応式

HRID 352619 の反応式
[N:1]1[CH:6]=[CH:5][CH:4]=[N:3][CH:2]=1.[Li+].[OH-].CN(C(ON1N=[N:24][C:19]2C=C[CH:22]=[N:23][C:18]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CC[N:35]([CH:39]([CH3:41])C)[CH:36]([CH3:38])[CH3:37].[CH2:42]([NH2:52])[C:43]1[CH:51]=[CH:50][C:49]2[O:48][CH2:47][O:46][C:45]=2[CH:44]=1.[CH2:53]1[CH2:57][O:56][CH2:55][CH2:54]1.O>>[O:48]1[C:49]2[CH:50]=[CH:51][C:43]([CH2:42][NH:52][C:55]([C:54]3[CH:37]=[C:36]4[C:38]([CH:41]=[CH:39][N:35]4[C:6]4[CH:5]=[CH:4][N:3]=[C:2]([N:23]5[CH:18]=[CH:19][N:24]=[CH:22]5)[N:1]=4)=[CH:57][CH:53]=3)=[O:56])=[CH:44][C:45]=2[O:46][CH2:47]1

参加物

7

反応物 6

HCID 3939Lithium HydroxideHCID 9260PyrimidineHCID 75799Benzo-1,3-dioxole-5-methylamineHCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 21881883Oxolane--water (1/1)

生成物 1

HCID 22487625n-[(1,3-Benzodioxol-5-yl)methyl]-1-[2-(1h-imidazol-1-yl)pyrimidin-4-yl]indole-6-carboxamide収率 4%

反応条件

温度
60 °C

実験手順

To a solution of indole-5-carboxylic acid (0.50 g, 3.1 mmol) in MeOH (25 mL) was added trimethylsilyidiazomethane until no gas evolution was observed. The solution was concentrated, dissolved in CH2Cl2, and washed with saturated NaHCO3 and brine. The organic layer was dried (MgSO4) and the solvent was removed in vacuo to give 0.54 g of the ester (1H NMR (CDCl3) δ3.95 (s, 3), 6.63 (s, 1), 7.25 (m, 1), 7.40 (d, 1), 7.95 (d, 1), 8.25-8.4 (br s, 1), 8.45 (s, 1)). The ester (100 mg, 0.58 mmol) was dissolved in DMF (10 mL) and 4-chloro-2-imidazol-1-ylpyrimidine (113 mg, 0.63 mmol) was added. After heating at 60° C. for 18 hours, the solvent was removed in vacuo, the residue was dissolved in CH2Cl2, and washed with saturated NaHCO3 and brine. The organic layer was dried (MgSO4), the solvent was removed in vacuo and the residue was chromatographed (CH2Cl2/MeOH, 19/1) to give 68 mg (37%) of the pyrimidine (1H NMR (CDCl3) δ3.95 (s, 3), 6.90 (s, 1), 7.25 (m, 2), 7.80 (m, 1) 7.95 (s, 1), 8.10 (d, 1), 8.4 (s, 1), 8.50 (d, 1), 8.70 (m, 2)). The pyrimidine was dissolved in THF/water (1/1) and LiOH (6 mg, 0.21 mmol) was added. After heating at 60° C. for 3 hours, the solvent was removed in vacuo and acidified with methanolic HCl. The solvent was removed in vacuo, dissolved in DMF and treated with HATU (42 mg, 0.11 mmol), DIEA (37 mg, 0.21 mmol), and piperonylamine (26 mL, 0.21 mmol). After stirring for 18 hours, the solvent was removed in vacuo, the residue was dissolved in CH2Cl2, and washed with saturated NaHCO3 and brine. The organic layer was dried (MgSO4), the solvent was removed in vacuo, and the residue was chromatographed (CH2Cl2/MeOH, 19/1) to give 2 mg (4%) of N-[(1,3-benzodioxol-5-yl)methyl]-1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]indole-6-carboxamide; 1H NMR (CDCl3) δ3.75 (s, 2), 5.95 (s, 2), 6.80-6.90 (m, 2), 7.05-7.15 (m, 2), 7.25 (m, 2), 7.75-7.85 (m, 2), 8.00 (s, 2), 8.50-8.60 (m, 2), 8.70-8.80 (m, 1); MS: (439.2 M+H)+.

後処理

  1. customthe solvent was removed in vacuo
  2. customThe solvent was removed in vacuo
  3. dissolutiondissolved in DMF
  4. customthe solvent was removed in vacuo
  5. dissolutionthe residue was dissolved in CH2Cl2
  6. washwashed with saturated NaHCO3 and brine
  7. dry with materialThe organic layer was dried (MgSO4)
  8. customthe solvent was removed in vacuo
  9. customthe residue was chromatographed (CH2Cl2/MeOH, 19/1)

出典と根拠

ORDレコード
ord-319b8550252d4a288cb28b138463381c
出典データセット
uspto-grants-2004_06
特許番号
US06747031B2

関連ノート

読み込み中…